RFL
NYSE · Pharmaceuticals
Rafael Holdings Inc-Class B
$1.24
-0.02 (-1.59%)
Open$1.24
Previous Close$1.26
Day High$1.30
Day Low$1.24
52W High$3.19
52W Low$1.12
Volume—
Avg Volume100.2K
Market Cap67.11M
P/E Ratio—
EPS$-0.85
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.61M | 1.23M | 15.20M |
| Net Income | -53,614,774 | -36,896,541 | 4.84M |
| Profit Margin | -3,328.2% | -3,161.8% | 31.9% |
| EBITDA | -50,175,375 | -36,447,932 | 7.34M |
| Free Cash Flow | — | — | 4.44M |
| Rev Growth | +30.8% | +30.8% | +5.7% |
| Debt/Equity | 0.01 | 0.01 | 0.33 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |